Albert Labs

Albert Labs is the first psychedelics company pioneering Real World Evidence Studies in hospital settings across the UK & Europe to deliver treatment therapies for urgent, unmet needs.

Through a collaboration with leading academic institutions, hospital networks and existing reimbursement mechanisms; Albert Labs empowers scientists, researchers, and medical professionals to accelerate safe patient treatment whilst collecting data to protect and improve its psilocybin based medicines.

Starting with cancer-related anxiety, depression and existential crisis, Albert Labs will bring psilocybin-assisted therapy to the UK and Europe before expanding globally.

View in the Microdose DirectoryVisit Website